Impact of KRAS , BRAF , PIK3CA , TP5 3 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases-Reference-Cited by-同舟云学术

Impact of KRAS , BRAF , PIK3CA , TP5 3 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases

Published:2016-04-04 Issue:3 Volume:139 Page:647-656
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Løes Inger Marie¹²,Immervoll Heike³,Sorbye Halfdan¹²,Angelsen Jon‐Helge⁴⁵,Horn Arild⁵,Knappskog Stian¹²,Lønning Per Eystein¹²

Affiliation:

1. Department of Clinical ScienceUniversity of BergenBergen Norway

2. Department of OncologyHaukeland University HospitalBergen Norway

3. Department of PathologyÅlesund HospitalÅlesund Norway

4. Department of Clinical MedicineUniversity of BergenBergen Norway

5. Department of Digestive SurgeryHaukeland University HospitalBergen Norway

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30089

Reference50 articles.

1. Changing patterns of recurrent disease in colorectal cancer

2. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

3. Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure

4. Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

5. Survival after liver resection in metastatic colorectal cancer: review and meta‐analysis of prognostic factors;Kanas GP;Clin Epidemiol,2012

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Präzisionsmedizinischer Ansatz für die Metastasenchirurgie viszeraler Tumoren;Die Onkologie;2024-08-21

2. Utility of circulating tumor DNA in secondary liver malignancies: What we know and what is to come;Journal of Surgical Oncology;2024-08-19

3. Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study;British Journal of Surgery;2024-07

4. A panorama of colon cancer in the era of liquid biopsy;The Journal of Liquid Biopsy;2024-06

5. Construction and validation of “WCH‐nomogram” for predicting the prognosis after resection of colorectal liver metastases;Cancer Medicine;2024-05